Equipment & Consumables
Suppliers of surgical tools, hospital equipment and single-use products
Strategic clarity on durable assets and recurring use products
Assessing Growth in Medtech Equipment and Consumables
Medtech equipment and consumables underpin the daily functioning of health systems. Durable items such as hospital beds, surgical tools and mobility aids are essential infrastructure, increasingly influenced by ageing populations, chronic disease and the shift to home- and community-based care. Consumables — from sterile packs and syringes to single-use surgical components — provide recurring revenues but are subject to intense cost pressure and centralised procurement. Together, these categories form the dependable but competitive core of the Medtech sector.
We support investors and providers in evaluating opportunities across this spectrum. Our work includes commercial due diligence, portfolio reviews and growth strategy. We test product-level economics and procurement dynamics, benchmark competitive positioning, and assess where scale, service integration or digital innovation can provide a genuine edge. We also examine recurring revenue opportunities where equipment sales are complemented by consumables pull-through, creating a more resilient business model.
In the UK, the NHS spends more than £10bn annually on MedTech, with surgical equipment and consumables representing the largest share. Local authorities also procure adaptation equipment to support independent living, reinforcing the demand case but adding procurement complexity. Successful companies are those able to balance scale and breadth with credible innovation, proving value both in durable assets and consumables that sustain long-term relationships with health systems.
Our equipment & consumables leads
Our teams combine scientific expertise with deal experience. We bring rigour to forecasting and valuation, assess regulatory and market access dynamics, and help frame development strategies that appeal to potential partners or acquirers. This ensures that investment cases are built on realistic assumptions and that transactions are structured to capture fair value.
Beyond transactions, we support operational priorities such as target operating model design, performance improvement, and digital and data strategy. By combining strategic clarity with an understanding of scientific and clinical realities, we help biotech firms and their backers make sound decisions in an increasingly competitive market.
News & Insights
Our medtech Insights
News & Insights
Healthcare news, data and analysis
Via Investors in Healthcare
